Skip to main content
. Author manuscript; available in PMC: 2015 Nov 4.
Published in final edited form as: Neuropharmacology. 2013 Sep 18;77:145–155. doi: 10.1016/j.neuropharm.2013.09.003

Fig. 1.

Fig. 1

Schematic illustration showing the timing of developmental chronic in vivo treatments in both genotypes, the ages at which young and adult male offspring were examined, and the measurements that were made from layer VI pyramidal neurons.